Inventor
Gaetan H. Ladouceur
Inventor
Guilford, CT, US
Overview
Patents· 24 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds43%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations36%
A61KPreparations for medical, dental or toiletry purposes13%
A61LMethods or apparatus for sterilising materials or objects in general2%
C07CAcyclic or carbocyclic compounds2%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium2%
G01NInvestigating or analysing materials by determining their chemical or physical properties2%
PatentTitleYear
8,796,250'Diaryl ureas for diseases mediated by PDGFR'20148,501,755'Tetrahydropyridothienopyrimidine compounds and methods of use thereof'20138,207,166'Substituted pyrazolyl urea derivatives useful in the treatment of cancer'20127,838,524'Substituted pyrazolyl urea derivatives useful in the treatment of cancer'20107,803,956'Benzofuran derivatives useful for treating hyper-proliferative disorders'20107,659,412'Benzofuran derivatives useful for treating hyper-proliferative disorders'20107,585,888'Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders'20097,429,584'Furo[2.3-b]pyridine derivatives for the treatment of hyper-proliferative disorders'20087,420,066'Benzofuran derivatives useful for treating hyper-proliferative disorders'20087,384,947'Fused tricyclic heterocycles useful for treating hyper-proliferative disorders'20087,351,735'Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders'20087,238,701'Substituted tetrahydrobenzothienopyrimidinamine compounds useful for treating hyper-proliferative disorders'20077,144,885'Fused tricyclic heterocycles useful for treating hyper-proliferative disorders'20066,919,371'2,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonists'20056,903,218'Sulfonamide substituted chroman derivatives'20056,780,859'Benzofuran and dihydrobenzofuran derivatives useful as beta-3 adrenoreceptor agonists'20046,699,860'Di-substituted aminomethyl-chroman derivative beta-3 adrenoreceptor agonists'20046,660,752'2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists'20036,410,792'Amide derivatives and methods for using the same as selective neuropeptide Y receptor antagonists'20026,245,817'NPY5 receptor antagonists and methods for using same'20016,218,431'Substituted biphenyls'20016,051,586'Sulfonamide substituted chroman derivatives useful as beta 3 adrenoreceptor agonists'20006,048,900'Amide derivatives and methods for using the same as selective neuropeptide Y receptor antagonists'20005,939,462'NPY5 receptor antagonists and methods for using same'1999Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1999–2002Patents assigned to BAYER AG (6)· patent assignee history
1999–2005Based in Branford, CT, US· patent location history
2003–2010Patents assigned to BAYER PHARMACEUTICALS CORP (12)· patent assignee history
2006–2014Based in Guilford, CT, US· patent location history
2008–2014Patents assigned to BAYER HEALTHCARE LLC (5)· patent assignee history
2012–2014Patents assigned to LADOUCEUR GAETAN (3)· patent assignee history
2012–2014Patents assigned to DUMAS JACQUES (2)· patent assignee history
2013Based in Rockville, MD, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BAYER PHARMACEUTICALS CORP | 12 | 2003–2010 |
| BAYER AG | 6 | 1999–2002 |
| BAYER HEALTHCARE LLC | 5 | 2008–2014 |
| LADOUCEUR GAETANself | 3 | 2012–2014 |
| DUMAS JACQUES | 2 | 2012–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Guilford, CT, US | 12 | 2006–2014 |
| Branford, CT, US | 11 | 1999–2005 |
| Rockville, Maryland, US | 1 | 2013 |